Pain
Novel neurotrophin-3 inhibitor offers ‘real hope’ for patients with osteoarthritis pain
WASHINGTON — Patients treated with a novel neurotrophin-3 inhibitor demonstrated significant reductions in osteoarthritis knee pain across all dosing levels, according to data presented at ACR Convergence 2024.
Pain management training may benefit patients on hemodialysis
SAN DIEGO — Pain coping skills training may be beneficial for pain interference and related outcomes for patients on hemodialysis, according to data presented at ASN Kidney Week.
More than half of patients with rheumatic, musculoskeletal disease use OTC supplements
More than 54% of patients with rheumatic and musculoskeletal diseases report daily use of over-the-counter supplements, with “considerable” intake alongside pain relievers, according to data published in Rheumatology Advances in Practice.
Intrauterine lidocaine reduces pain during, after hysteroscopy-guided biopsy
DENVER — Women undergoing endometrial biopsy using vaginoscopic hysteroscopy reported less pain and were discharged sooner when the procedure was performed with intrauterine lidocaine compared with placebo, researchers reported.
VIDEO: Lifestyle medicine program improves musculoskeletal surgical outcomes
ORLANDO — Adhering to an intensive lifestyle medicine program before orthopedic surgery led to fewer postoperative outcomes and less pain in patients, according to a study.
Managing migraine pain before it begins: Understanding prodrome, early treatment options
Migraine is a complex neurological disease that disproportionately affects women during their most productive years.
Kidney transplant patients with more pain report less involvement in social activities
SAN DIEGO — Kidney transplant recipients who experience more bodily pain have less involvement and ability to participate in social activities than kidney transplant patients who report less pain, according to data at ASN Kidney Week.
Open-label placebo injection demonstrates ‘modest’ benefit in chronic back pain
A single saline injection, openly prescribed as a placebo, yielded approximately 1 month of chronic back pain improvement, along with longer-term benefits in depression and sleep, according to data published in JAMA Network Open.
Okyo Pharma initiates phase 2 trial of OK-101 for neuropathic corneal pain
Okyo Pharma has announced that screening and recruitment has been initiated for a phase 2 trial of OK-101 to treat neuropathic corneal pain, with plans to enroll 48 patients, according to a company press release.
Dual interventions best for osteoarthritis knee pain, non-exercise methods best for hips
Knee osteoarthritis pain responds best to exercise combined with a non-exercise intervention, such as diet, while hip osteoarthritis moderately benefits from non-exercise interventions vs. resistance exercise, according to data.